The present disclosure concerns a support device comprising a mattress capable of supporting a patient in a lying position, as well as a device for laterally tilting said patient thus lying on the mattress. More specifically, this disclosure concerns a lateral tilting device capable of being inserted between said mattress and a base or frame of a bed or chair adapted for medical use upon which it rests.
It is known that a therapeutic support device can comprise a mattress resting or capable of resting on a base or frame, said mattress comprising a plurality of transversal inflatable cells, more or less cylindrical, each extending in a lateral direction perpendicular to the longitudinal direction of the mattress, said transversal cells being laid out side by side in the longitudinal direction of the mattress, the support device moreover comprising the means of inflating said cells and, preferably, the electronic means of regulating the air pressure within said cells, preferably also according to the morphology of the patient lying upon said mattress.
In some such support devices, each cell is equipped in a known manner with an air feed orifice and an air evacuation orifice, which communicate in a substantially airtight manner through hoses and by means of electromagnetic valves opening or closing said orifices, with an inflating device, such as a pump and electronic control devices of said pump and said electromagnetic valves.
The support devices of this type are used as mattresses for caring for patients, because they make it possible to ensure an adequate distribution of the interface pressure, that is to say, a pressure exerted locally by each point of the body on the surface of the mattress, according to the morphology and the position of the patients. Such mattresses specifically make it possible, as a function of the number of inflatable cells implemented, to individually control the pressure and thus the filling of the inflatable cells in the different areas of the mattress in order to obtain a redistribution of the interface pressure suited to the level of each of the parts of the body of a patient and to avoid or reduce the risk of formation of bedsores in a patient at risk, for example in the vulnerable regions of the body, such as the sacrum and the heels.
Theoretically, the ideal comfort of a patient and the optimum vascularization particularly for preventing the formation of bedsores or for reducing localized pain in certain support areas of the body on the mattress, are notably obtained when the support points of the body are redistributed over the surface of the mattress, that is to say, when the pressure exerted by the various areas of the body on the mattress (called “interface pressure”) are more or less identical for all the of the body surface in contact with the mattress and, moreover, if such surface contact of the body with the mattress is as great as possible, which sometimes involves the adapting of the inflatable cells of the mattress under the various parts of the body to control the level of penetration of the body into the various areas of the mattress.
To accomplish this, the air pressure within the inflatable cells sometimes is distributed by controlling the filling/emptying of them according to certain pre-established calculations based on and according to the measurements made with sensors, in, on or under the mattress depending on the type of sensors utilized. Such sensors, known by people skilled in the art, can measure the pressure exerted by the patient's body or the penetration of the patient's body into the given compartments of the mattress, as described for example in the European patent EP 0 676 158 and European patent EP 1 056 372, as well as unpublished patent application FR 09 53758 filed on Jun. 5, 2009 (the US counterpart of which is U.S. application Ser. No. 12/781,426 filed May 17, 2010) describing pressure sensors comprising a capacitive measuring cell, on behalf of the claimant, each of which is hereby incorporated into this description by reference.
The control and regulation of the filling/emptying of the inflatable elements by means of electromagnetic valves also makes it possible to provide support devices functioning in the so-called “alternating pressure mode” in which certain inflatable cells of the support device regularly distributed over the length of the latter are alternately and simultaneously inflated and deflated. For example, one of two cells, or of three, or even of four is deflated/reinflated, then the adjacent cells to the previously deflated then reinflated cells are deflated/reinflated. Thus, each inflatable cell of the support device is successively deflated/reinflated from one cell to another, creating a sort of wave moving in the longitudinal direction of said device back and forth and relieving the interface pressure locally, facilitating at this point the vascularization of the soft tissue at the interface with the surface of the support device.
Some of the prior art support devices, specifically the mattresses, incorporating such inflatable cells consist, for example, of a first layer, the geometry of which in some instances is kept fixed due to the construction and which generally consists of an air mattress, the envelope of which is not elastic or of a foam bed, of a generally constant thickness throughout the mattress, forming a so-called lower mattress. A second layer lies on this, generally called a “therapeutic mattress,” formed by juxtaposing inflatable cells, generally in the form of more or less cylindrical cells or rolls lying extended in a direction perpendicular to the longitudinal direction of the mattress, welded to one another over their length or only connected to one another at their ends in the transversal direction of the mattress. Each of the areas of the therapeutic mattress is equipped with electromagnetic valves and suitable hoses capable of being connected to an inflation and regulating device, generally independent of the mattress. The lower foam mattress layer, when there is such, and the therapeutic mattress layer consisting of inflatable cells are enclosed in a specially adapted slipcover to enable the filling and emptying of the inflatable rolls of the therapeutic mattress through its hoses connected to an attached inflation and regulating device.
Such mattresses with at least a partially inflatable structure make it possible to assist the prevention, and the effective and increased treatment of bedsores and other injuries or pain associated with keeping patients in a lying and nearly immobile position on hospital beds for a prolonged time, specifically through the implementation of alternating cycles of inflation/deflation of the cells of the therapeutic mattress and a use of differentiated inflation pressures of the cells in relation to the different support areas of the patient's body.
It is sometimes desirable to position the patient on their left side or right side, either to provide care, or to prevent the formation of bedsores or to reduce the localized pain in certain support areas of the body on the mattress, by modifying the location of such support zones through the alternate tilting or rotation of the body to one side then to the other. This practice is sometimes established as 30° lateral decubitus [reclining position] as described below.
To this end, attending staff may possibly use the blocks of foam of a specific shape supplied both as accessories or custom-built for each case, or else they use pillows or headboards that are placed in between the mattress and the patient, such that the body forms a 30° angle with the upper surface of the mattress, while benefitting from a back support and without the perineum contacting the mattress. In some instances, the legs are flexed in the area of the hips and the knees and wedged between them by cushions or foam shapes adapted so as to minimize the support risks between the bony projections. The upper leg is positioned behind the lower leg and flexed at 30° at the hip level and 35° at the knee level, for example.
It is known that some such prior art devices do not allow for the inclination of the mattress and to ensure the continuity of therapeutic performance in terms of pressure regulation of the various areas of the mattress, specifically in relation to the supporting side in the area of the bony projections, such as the large trochanter even between the bony projections themselves, particularly the knees and the ankle bones [malleolus], without interfering with the patient's movements, which can likewise compromise the therapeutic benefits sought or his/her safety in the event of a fall or entrapment in the spaces between the mattress and the bed.
Finally, repeated sequences of alternate lateral movements of the patient's body are not easily done and can possibly require, in some instances, attending personnel to be available to see that the patient remains comfortable in a lateral position for several hours. Moreover, it may be difficult to do, depending on the morphology and pathology of the patient, and may even cause a back injury for the attending personnel. Finally depending on the equipment used, for example, with foam forms, hygienic safety can be difficult to maintain and the material used can be lost, damaged or difficult to manage with respect to its storage and monitoring.
This disclosure provides an improved type of support device, offering a patient functional lateral tilting, that is integrated into the mattress that is safe. It also can be controlled in terms of the incline angle of the mattress on which the patient lies on the one hand, and on the other, capable of being done cyclically according to the durations of the different stages of the cycle of alternated lateral tilting from one side to the other, in a controlled and reliable manner.
To this end, this disclosure offers a device for laterally tilting a patient lying on a mattress, capable of being inserted between said mattress and a bed base or bed frame on which said mattress lies, characterized in that said lateral tilting device comprises at least two first and second inflatable cells, pneumatically independent and positioned at least partially symmetrically to each other in relation to a median axis of said tilting device, the shape in the inflated state being capable of creating a lateral incline of the mattress when a first cell is inflated more than the second cell and a lateral incline sloping in the opposite direction when said second cell is inflated more then said first cell, said tilting device being inserted between the mattress and a bed base or bed frame on which it rests, with a median axis of said tilting device positioned so as to make it roughly coincide with a longitudinal median axis of said mattress.
By “pneumatically independent” herein, it is understood that said cells are capable of being inflated with air or deflated independently and differently from one another and if desired, independently and differently from the inflatable cells comprising said mattress under which the tilting device is inserted.
This disclosure likewise provides a support device comprising a mattress capable of supporting a patient in a lying position and a lateral tilting device according to the disclosed embodiments, the tilting device being laid out under the mattress inserted between a base or frame and the mattress, and said first and second cells extending in the longitudinal direction of the mattress.
Optionally, said mattress includes a plurality of pneumatically independent inflatable transversal cells and extends in a direction perpendicular to the longitudinal direction of the mattress and side by side in the longitudinal direction of the mattress, the pressure within said transversal cells capable of being regulated at a controlled pressure by means of inflation-deflation or electronically, in relation to the air pressure values measured in the cells and the morphology, the position and/or penetration of the patient into the mattress as determined by a sensor inserted between said mattress and said tilting device.
In some embodiments, said morphology and position sensor, for example a capacitive sensor type, is integrated into the mattress and subject to the same tilting as the latter. The morphology and position sensor, for example a capacitive sensor type, can also be capable of automatically determining the tilt angle before it begins. In any event, a support device according to the present disclosure potentially includes a way of controlling the tilt angle either through support information coming from said morphology and position sensor, or by direct measurement of the angle or any other appropriate means.
In some contemplated embodiments, said mattress comprises said transversal cells resting on a lower mattress or a lower layer preferably consisting of cell(s) filled with air, said tilting device being inserted between said bed frame or bed base and under the mattress.
This disclosure likewise provides a lateral tilting method for a support device characterized in that the tilting of said mattress is done by inflating a said first or second cell and concomitant deflating of the other second or respectively first cell of said tilting device laid out under said mattress.
In some embodiments of the lateral tilting device according to this disclosure, each cell includes at least 2 longitudinal form compartments, preferably more or less cylindrically shaped, of the roll type, the two compartments of each said cell of each group not being laid out symmetrically to one another in relation to the median axis of said tilting device, and the compartment of each said first or second cell closest to the median axis of said tilting device having a lower height than that of the other compartment of the same inflated cell, so as to create the lateral incline of the mattress when said tilting device is inserted between said mattress and said bed base or bed frame, with the median axis of said tilting device positioned so as to make it roughly coincide with the medium longitudinal axis of said mattress.
It is therefore possible that, in a lateral tilting method of the support device according to the present disclosure, when each cell of the tilting device includes two compartments, as described above, the height of the small compartment of the inflated cell is higher than the height of the large compartment of the other deflated cell preferably located on the same side of the median axis of the tilting device following the deflation, such that an incline of the mattress is obtained following a concomitant inflation-deflation of the two cells.
Other forms of cells for a tilting device were tested, single large compartments rather than being paired with small compartments and/or large compartments were paired with adjacent small compartments that create a less homogeneous incline of the mattress, which could be harmful to the stability and the safety of the patient, or do not create the sought inclined plane.
More specifically with regard to some embodiments, in a lateral tilting device according to the present disclosure, said first and second cells extend to a length at least equal to ⅔, preferably at least to ¾ of the length of said mattress, more preferably the length of said first and second cells is at least 1.50 m. Such a length of the cells of the tilting device according to some embodiments of this disclosure, extending over almost the entire length of the body of a patient lying on said mattress makes it possible to avoid the risks of twisting with potentially negative effects on the patient in the case of a cell extending over a shorter length.
According to some other aspects and characteristics of a tilting device according to some embodiments contemplated by this disclosure: the compartments of greater height and compartments of lesser height of each of said first and second cells are located on either end of said longitudinal median axis of the tilting device, and the two compartments of the same said first or second cell communicate pneumatically between one another. In other embodiments, the two compartments of each cell can be pneumatically independent.
In some embodiments of a lateral tilting device according to the disclosure, the latter includes two first and second cells joined with one another, said cells each including at least two compartments communicating with one another, the two compartments of each cell defining a ‘U’ with branches laid flat, including in the inflated state:
The embodiments of the type mentioned in the preceding paragraph can potentially be advantageous in terms of the manufacturing cost. For example, the first and second cells can be mechanically unified with one another through heat-sealing lines of two sheets of plastic material or of cloth coated with plastic material, one against the other, or one sheet of plastic material or of cloth coated with plastic material folded on itself, with said heat-sealed lines forming in addition at least two said compartments, communicating with at least two said junction areas extending transversally between each of said compartments of each of the two cells permitting pneumatic communication between the two compartments at one of their longitudinal ends. In another contemplated embodiment, the junction areas between the two compartments are not formed by heat-sealing of said sheets or of plastic material or cloth coated with plastic material, but by a single hose fixed to the sealing orifices on each of the two said compartments at each of the ends of said hose.
In some embodiments having means of inflation-deflation including at least a pump, inflation-deflation orifices of said first and second cells and independent pneumatic means of communication, such as hoses between said pump and said orifices, are provided and said means of inflation includes an automatic electronic regulating device for the alternating inflation-deflation of the two first and second cells capable of controlling the inflation of a cell and concomitant deflation of the other cell, and successively inflating then deflating each said first and second cell according to cycles of different possible durations, such as with time durations from 30 seconds to 4 hours maintaining the inflated state of each cell and maintaining the deflated state.
More specifically, with regard to some embodiments, the respective height of each said first and second cell at the maximum inflation and respectively minimum state permits a said lateral incline of at least 20°, preferably 25°. This incline is sufficient to completely tilt a patient to one side. For example, the convex pumped upper faces of the two compartments are more or less tangent to a straight line inclined with respect to the horizontal with an angle up to at least 20°, preferably 25°, when the lower faces rest on a horizontal plane.
The embodiments according to the present disclosure can likewise be used in an alternated tilting method, wherein an inflation-deflation cycle is implemented for each said first and second cell successively, to perform the lateral tilts of said mattress alternately on each side, the lateral incline of the mattress possibly being tilted at 4 to 8°, to 5 to 7°, with said cells of the tilting device being inflated at a regulated pressure, like the transversal cells of said mattress, said regulated pressure being still differentiated according to the areas of the mattress in the longitudinal direction of said mattress. This allows for an automated sequential lateral releasing of the support points of the patient on the mattress without creating hyper-pressure.
The sensor thus remains activated to regulate the pressure within the mattress, like that within the inflated cell of the tilting device at the determined inflation pressure. And, the morphology and position sensor according to some embodiments of the present disclosure make it possible to ensure the continuity of therapeutic benefits, a low angulation and the safety of the patient at the time of the tilting.
This relatively low angle actually makes it possible to prevent risks of abrasion or cutting the soft tissue of the patient, and an alternating lateral incline of 5 to 7° likewise makes it possible to keep the patient safe, as the risk of falling is not increased with respect to the flat position. Optionally, in this method according to the present disclosure, the alternating tilting cycles are performed with durations of time from 1 to 3 hours, where the inflated state of each of the first and second cells is maintained, and then the first and second cells are maintained in the deflated state.
In each particular implementation mode, said cells may be comprised of plastic material, such as PVC or PU (polyurethane) or of cloth coated with plastic such as PVC or PU.
Additional features, which alone or in combination with any other feature(s), such as those listed above and those listed in the claims, may comprise patentable subject matter and will become apparent to those skilled in the art upon consideration of the following detailed description of various embodiments exemplifying the best mode of carrying out the embodiments as presently perceived.
The detailed description particularly refers to the accompanying figures in which:
The different cells of areas 19, 15, 16, 17 and 9 are respectively supported by two lower mattresses 13-1 and 13-2, while the calf support area 18 is supported by a service unit 14 containing an air feed pump and electronic means of control of the opening of the electromagnetic air feed and air evacuation valves of the various pneumatically independent cells, as well as the electronic controls for regulating the pressure in relation to the air pressure measurements within the cells and an interface pressure measurement given by a sensor 5 placed in a known manner under the sacrum area, in the space under the lower mattress 13-2 in a central position of the sacrum area 16, enabling the providing of data relating to the morphology of the patient as a function of the penetration of the patient into said mattress, as determined by said sensor. It is particularly possible to use a capacitive sensor as described in application FR-09 53758 filed on Jun. 5, 2009 on behalf of the claimant incorporated in this description as a reference.
The two compartments 1a, 2a, 1b, 2b of each cell 1, 2 exhibit a more or less cylindrical axial shape extending in parallel to the X1X′1 direction with a roughly oval transversal section, as depicted in
Each of these two large compartments 1a, 2a exhibits a maximum dimension in the transversal YY′, direction, I1=47 cm and each said small compartment 1b, 2b exhibits a maximum dimension in the transversal YY′ direction, I2=26 cm. The maximum width dimensions of the large and small compartments given above correspond to the width of the compartment in the completely deflated state, upper and lower faces of each compartment being laid out flat one on top of the other.
It is known that the width of said compartments is progressively reduced as they inflate, such that once said tilting device is inflated with its longitudinal median X1X′1 axis coinciding with the longitudinal median XX′ axis of the mattress, the tilting device does not exceed the width of said mattress.
The fact that the small compartment of each cell is located on the other side of the median X1X′1 axis of the device in relation to the other compartment, with the small compartment of each cell positioned just after the median X1X′1 axis and the large compartment of each cell positioned in the vicinity of the outside edge of the mattress, makes it possible to create an optimal lateral incline of the mattress while preventing the formation of a cup in the area of the median X1X′1 axis of the mattress. Such a cup could be created if the two compartments of each cell were located on the same side in relation to the median axis X1X′1 of said tilting device and thus in relation to the longitudinal median XX′ axis of the mattress.
The large and small compartments of each cell are spaced in the transversal YY′ direction of a length L2. The small compartments 1b and 2b are smaller than the large compartments 1a and 2a of a length L1 of a maximum dimension equal to 30 cm. The large and small compartments of each cell communicate with one another at their longitudinal ends through a transversal junction area 1c, 2c forming two ‘L1’ shaped cells with the two large and small compartments of each cell.
The two ‘U’ cells 1, 2 are fit into one another such that the small branch or small compartment 1b, 2b of each cell 1, 2 is inserted between the two branches or compartments 2a-2b, 1a-1b of the other cell, the edges of said small branch 1b-1, 1b-2 and 2b-1, 2b2 of each cell being joined with the internal longitudinal edges 1a2, 1b2 and 2a2, 2b2 of the 2 branches of the other cell.
A thus designed tilting device is noteworthy, because it can be easily manufactured by heat-sealing two sheets of plastic material or cloth coated with plastic material, together particularly polyurethane coated cloth, such that the weld lines simultaneously define the circumference 3a of the two cells and the connection line between the two cells.
Thus, internal longitudinal edges 1a2 and 2a2 of the large branches 1-2 and 2a are joined to external longitudinal edges 2b1 and 1b1 of small branches 2b and 1b of the other cell. And internal longitudinal edges 1b2 and 2b2 of each small compartment are joined to one another. In addition, internal edge 1c1-2c1 of each transversal junction area 1c, 2c of each cell is joined to the transversal edge 1b3, 2b3 of longitudinal end of the small compartment comprising the small branch of the ‘U’ of the other cell.
The weld line between the two internal edges 1b2, 2b2 of the two small compartments 1b, 2b coincide with the longitudinal median X1X′1 axis of device 3, such that when tilting device 3 is positioned under a mattress 10, causing longitudinal X1X′1 axis of the tilting device to coincide with longitudinal XX′ axis of the mattress with at least one of first and second cells 1, 2 inflated to the maximum, tilting device 3 exhibits a width L slightly less than the width of the mattress, in the space here less than 85 cm, in the maximum inflation position of one of the 2 cells 1 or 2 only, the heights H and h of the large compartments 1a, 2a and small compartments 1b, 2b, being H=30 cm and h=10 cm.
To laterally tilt from the other side, outside edge 1a-1 of large branch 1a of the other cell, reaches the proximity of the lateral edge closest to the mattress and internal edge 1b-2 of small branch 1b of the other cell, which reaches the area of the median action XX′ axis of the mattress.
They are inflated to the maximum to obtain the maximum heights H and h of the large and small compartments of one of the cells to facilitate the complete lateral tilting of a patient onto the one side with an incline of the mattress of α=20 to 25° for the purpose of providing specific care to the patient.
However, this embodiment provides a comfortable method of treating the patient through an alternating lateral tilting procedure by alternate inflation of each of the two first and second cells 1, 2, the other being deflated or in any case less inflated, as is particularly apparent in view of the diagram of
Straight line D1 tangent to the two large and small compartments of each inflated cell form an angle α to the horizontal, of a maximum of 20 to 25°, which is sufficient to produce the complete tilting of a patient onto the side. And, in the case of a treatment for comfort intended solely to alleviate or prevent the risk of appearance of bedsores, alternate tilts with an incline of 5 to 7° of the right side and of the left side are sufficient.
It is clear that depending on the degree of inflation of the different cells and according to the internal air pressure within the two cells 1, 2, it is possible to produce a controlled inclining of the bedridden patient on an air mattress regulated at the control pressure; the inflation of the two first and second cells of tilting device 3 according to the present disclosure can be controlled entirely automatically and sequentially.
Tilting device 3 is joined on the under face of mattress 10, if desired of lower mattress 13-1, by a longitudinal zipper (not shown), so that the two X1X′1′ axes of tilting device and XX′ of the mattress coincide. Thus, during inflation (or deflation) only a lateral half of the device, including the large compartment of one cell and the small compartment of the other change their overall width, the large compartment once inflated being always entirely located under the mattress by reduction of its width in conjunction with the increase of its height.
The cycle, that is the time period of maintaining each position, can be controlled automatically. And the pressure of therapeutic mattress 10 can likewise be controlled automatically by means of sensor 5, which remains active even during the lateral tilting, because the overall width of each inflated cell exceeds the longitudinal median XX′ axis of the mattress from the longitudinal lateral edge of the most distant mattress. Patient 20 thus rests the entire time on an active therapeutic surface 10. Barriers 12 and alarms (not shown) can be activated during the cycle time of an alternate tilting procedure to prevent the patient from possibly falling from mattress 10.
Optionally, the two cells 1, 2 can be inflated to the same control pressure as that of mattress 10, in the region of the sacrum area, which is determined and controlled in connection with sensor 5 controlling the immersion of patient 20, specifically an ultra flat and shapeable capacitive sensor, as described in FR 09 53758 (the US counterpart of which is U.S. application Ser. No. 12/781,426).
The purpose of the lateralization controlled by immersion sensor 5 is to reduce the interface pressure of one side of the patient, while ensuring adequate distribution of the support points over the opposite side that carries him/her, while preventing the creation of significant interface pressure points, the lateralization angles α in the in the alternating tilt procedure are small, from 5 to 7°, so as to avoid risks of abrasion and of cutting the soft tissue of the patient 20.
The two large and small compartments of each deflated cell are made virtually flat at the same time through activation of the large-flow electromagnetic valves, the patient's weight serving as additional support.
By default, the stages of the cycle are: lateralization to the right by inflating the first cell 1, reflattening of the first cell 1, lateralization to the left by inflating the second cell 2, reflattening of the first cell 2, and so on.
The time they are maintained in each stage is standardized at 2 hours by default. The sequences and duration times can be customized by the attending personnel, for example, in 30 minute increments.
Certain stages can be eliminated and a following sequence, for example, can be devised for which the right lateralization is maintained for a longer time than the left lateralization, for example 3 hours on one side and 2 hours on the other.
Sensor 5 remains active at the time of the lateralization, because it is dimensionally ultra-thin and shapeable, thus suited to such lateralization.
Sensor 5 can likewise be used to determine and control the value of the incline angle α of tilting device 3 at its maximum inflation pressure corresponding to said control pressure.
Although certain illustrative embodiments have been described in detail above, many embodiments, variations and modifications are possible that are still within the scope and spirit of this disclosure as described herein and as defined in the following claims.
Number | Date | Country | Kind |
---|---|---|---|
09 55935 | Aug 2009 | FR | national |
The present application is a continuation of U.S. application Ser. No. 12/856,076, filed Aug. 13, 2010, which claims priority, under 35 U.S.C. §119(a), of French National Application No. 0955935 which was filed Aug. 31, 2009 and each of which is hereby incorporated by reference herein.
Number | Name | Date | Kind |
---|---|---|---|
624638 | Fournier | May 1899 | A |
1147560 | Shurtleff | Jul 1915 | A |
1468072 | Ogle | Sep 1923 | A |
1772310 | Hart | Aug 1930 | A |
2245909 | Enfiajian | Jun 1941 | A |
2415150 | Stein | Feb 1947 | A |
2437006 | Simpson | Mar 1948 | A |
2460245 | Summerville | Jan 1949 | A |
2491557 | Goolsbee | Feb 1949 | A |
2575764 | Morner | Nov 1951 | A |
2604641 | Reed | Jul 1952 | A |
2719986 | Rand | Oct 1955 | A |
2998817 | Armstrong | Sep 1961 | A |
3148391 | Whitney | Sep 1964 | A |
3192540 | Swank | Jul 1965 | A |
3199124 | Grant | Aug 1965 | A |
3297023 | Foley | Jan 1967 | A |
3303518 | Ingram | Feb 1967 | A |
3317934 | Hinrichs | May 1967 | A |
3363941 | Wierwille | Jan 1968 | A |
3390674 | Jones | Jul 1968 | A |
3394415 | Parker | Jul 1968 | A |
3421163 | Stoughton | Jan 1969 | A |
3426373 | Scott et al. | Feb 1969 | A |
3446203 | Murray | May 1969 | A |
3462778 | Whitney | Aug 1969 | A |
3467081 | Glass | Sep 1969 | A |
3477071 | Emerson | Nov 1969 | A |
3485240 | Fountain | Dec 1969 | A |
3492988 | DeMare | Feb 1970 | A |
3587568 | Thomas | Jun 1971 | A |
3595223 | Castagna | Jul 1971 | A |
3605138 | Tucker | Sep 1971 | A |
3605145 | Graebe | Sep 1971 | A |
3644950 | Lindsay, Jr. | Feb 1972 | A |
3653083 | Lapidus | Apr 1972 | A |
3667073 | Renfroe | Jun 1972 | A |
3670347 | Weinstein | Jun 1972 | A |
3674019 | Grant | Jul 1972 | A |
3678520 | Evans | Jul 1972 | A |
3701173 | Whitney | Oct 1972 | A |
3740777 | Dee | Jun 1973 | A |
3757356 | Freeman | Sep 1973 | A |
3762404 | Sakita | Oct 1973 | A |
3775781 | Bruno et al. | Dec 1973 | A |
3784994 | Kery | Jan 1974 | A |
3795021 | Moniot | Mar 1974 | A |
3822425 | Scales | Jul 1974 | A |
3867732 | Morrell | Feb 1975 | A |
3870450 | Graebe | Mar 1975 | A |
3879776 | Solen | Apr 1975 | A |
3909858 | Ducker | Oct 1975 | A |
3919730 | Regan | Nov 1975 | A |
3935604 | Collins | Feb 1976 | A |
3949438 | Scales | Apr 1976 | A |
3955563 | Maione | May 1976 | A |
3978530 | Amarantos | Sep 1976 | A |
3982786 | Burgin et al. | Sep 1976 | A |
4005236 | Graebe | Jan 1977 | A |
4068334 | Randall | Jan 1978 | A |
4094025 | Nystad | Jun 1978 | A |
4099276 | Hunt et al. | Jul 1978 | A |
4132228 | Green | Jan 1979 | A |
4136413 | Scales | Jan 1979 | A |
4149285 | Stanton | Apr 1979 | A |
4175297 | Robbins et al. | Nov 1979 | A |
4185341 | Scales | Jan 1980 | A |
4190286 | Bentley | Feb 1980 | A |
4193149 | Welch | Mar 1980 | A |
4197837 | Tringali et al. | Apr 1980 | A |
4225989 | Corbett et al. | Oct 1980 | A |
4267611 | Agulnick | May 1981 | A |
4279044 | Douglas | Jul 1981 | A |
4280487 | Jackson | Jul 1981 | A |
4347633 | Gamoons et al. | Sep 1982 | A |
4391009 | Schild et al. | Jul 1983 | A |
4422194 | Viesturs et al. | Dec 1983 | A |
4428087 | Horn | Jan 1984 | A |
4454615 | Whitney | Jun 1984 | A |
4472847 | Gammons et al. | Sep 1984 | A |
4483030 | Flick et al. | Nov 1984 | A |
4488322 | Hunt et al. | Dec 1984 | A |
4508107 | Strom et al. | Apr 1985 | A |
4517693 | Viesturs | May 1985 | A |
4525885 | Hunt et al. | Jul 1985 | A |
4525886 | Savenije | Jul 1985 | A |
4527298 | Moulton | Jul 1985 | A |
4528704 | Wegener et al. | Jul 1985 | A |
4534078 | Viesturs et al. | Aug 1985 | A |
4541136 | Graebe | Sep 1985 | A |
4542547 | Sato | Sep 1985 | A |
4551874 | Matsumura et al. | Nov 1985 | A |
4583255 | Mogaki et al. | Apr 1986 | A |
4594743 | Owen et al. | Jun 1986 | A |
4614000 | Mayer | Sep 1986 | A |
4617690 | Grebe | Oct 1986 | A |
4622706 | Takeuchi | Nov 1986 | A |
4638516 | Vrzalik | Jan 1987 | A |
4638519 | Hess | Jan 1987 | A |
4642825 | Kurita | Feb 1987 | A |
4653130 | Senoue et al. | Mar 1987 | A |
4654903 | Chubb et al. | Apr 1987 | A |
4662012 | Torbet | May 1987 | A |
4686719 | Johnson et al. | Aug 1987 | A |
4686722 | Swart | Aug 1987 | A |
4688283 | Jacobson et al. | Aug 1987 | A |
4694520 | Paul et al. | Sep 1987 | A |
4697290 | Alklind et al. | Oct 1987 | A |
4698864 | Graebe | Oct 1987 | A |
4700418 | Ritter | Oct 1987 | A |
4711275 | Ford et al. | Dec 1987 | A |
4722105 | Douglas | Feb 1988 | A |
4729598 | Hess | Mar 1988 | A |
4745647 | Goodwin | May 1988 | A |
4768249 | Goodwin | Sep 1988 | A |
4797962 | Goode | Jan 1989 | A |
4798227 | Goodwin | Jan 1989 | A |
4799276 | Kadish | Jan 1989 | A |
4803744 | Peck et al. | Feb 1989 | A |
4825486 | Kimura et al. | May 1989 | A |
4838309 | Goodwin | Jun 1989 | A |
4840425 | Noble | Jun 1989 | A |
4852195 | Schulman | Aug 1989 | A |
4862921 | Hess | Sep 1989 | A |
4864671 | Evans | Sep 1989 | A |
4896389 | Chamberland | Jan 1990 | A |
4907308 | Leininger et al. | Mar 1990 | A |
4914760 | Hargest et al. | Apr 1990 | A |
4914771 | Afeyan | Apr 1990 | A |
4935968 | Hunt et al. | Jun 1990 | A |
4941221 | Kanzler | Jul 1990 | A |
4942635 | Hargest et al. | Jul 1990 | A |
4944060 | Peery | Jul 1990 | A |
4949412 | Goode | Aug 1990 | A |
4949413 | Goodwin | Aug 1990 | A |
4949414 | Thomas et al. | Aug 1990 | A |
4953247 | Hasty | Sep 1990 | A |
4962552 | Hasty | Oct 1990 | A |
4967431 | Hargest et al. | Nov 1990 | A |
5003654 | Vrzalik | Apr 1991 | A |
5005240 | Vrzalik | Apr 1991 | A |
5008965 | Vrzalik | Apr 1991 | A |
5022110 | Stroh | Jun 1991 | A |
5029352 | Hargest et al. | Jul 1991 | A |
5035014 | Blanchard | Jul 1991 | A |
5036559 | Hargest | Aug 1991 | A |
5044029 | Vrzalik | Sep 1991 | A |
5051673 | Goodwin | Sep 1991 | A |
5052067 | Thomas et al. | Oct 1991 | A |
5062167 | Thomas et al. | Nov 1991 | A |
5065464 | Blanchard et al. | Nov 1991 | A |
5065466 | Thomas et al. | Nov 1991 | A |
5073999 | Thomas et al. | Dec 1991 | A |
5090074 | Scales et al. | Feb 1992 | A |
5090077 | Caden et al. | Feb 1992 | A |
5092007 | Hasty | Mar 1992 | A |
5095568 | Thomas et al. | Mar 1992 | A |
5111544 | Graebe | May 1992 | A |
5121513 | Thomas et al. | Jun 1992 | A |
5138729 | Ferrand | Aug 1992 | A |
5142719 | Vrzalik | Sep 1992 | A |
5152021 | Vrzalik | Oct 1992 | A |
5152023 | Graebe | Oct 1992 | A |
5163196 | Graebe et al. | Nov 1992 | A |
5168589 | Stroh | Dec 1992 | A |
5182826 | Thomas et al. | Feb 1993 | A |
5235713 | Guthrie | Aug 1993 | A |
5249318 | Loadsman | Oct 1993 | A |
5251349 | Thomas et al. | Oct 1993 | A |
5269030 | Pahno et al. | Dec 1993 | A |
5323500 | Roe et al. | Jun 1994 | A |
5373595 | Johnson et al. | Dec 1994 | A |
5375273 | Bodine, Jr. et al. | Dec 1994 | A |
5388292 | Stinson | Feb 1995 | A |
5396671 | Stacy | Mar 1995 | A |
5421044 | Steenson | Jun 1995 | A |
5487196 | Wilkinson et al. | Jan 1996 | A |
5586346 | Stacy et al. | Dec 1996 | A |
5611096 | Bartlett et al. | Mar 1997 | A |
5926883 | Rechin et al. | Jul 1999 | A |
5983428 | Hannagan | Nov 1999 | A |
5983429 | Stacy et al. | Nov 1999 | A |
6021533 | Ellis et al. | Feb 2000 | A |
6145142 | Rechin et al. | Nov 2000 | A |
6216300 | Hannagan | Apr 2001 | B1 |
6295675 | Ellis et al. | Oct 2001 | B1 |
6421858 | Cuerel | Jul 2002 | B1 |
6467113 | Ellis et al. | Oct 2002 | B2 |
6536056 | Vrzalik et al. | Mar 2003 | B1 |
6584628 | Kummer et al. | Jul 2003 | B1 |
6760939 | Ellis et al. | Jul 2004 | B2 |
6904631 | Vrzalik et al. | Jun 2005 | B2 |
7076818 | Kummer et al. | Jul 2006 | B2 |
7111348 | Ellis et al. | Sep 2006 | B2 |
7322947 | Flick et al. | Jan 2008 | B2 |
7346945 | Phillips et al. | Mar 2008 | B2 |
7353556 | Ellis et al. | Apr 2008 | B2 |
7398573 | Ellis et al. | Jul 2008 | B2 |
7469436 | Meyer et al. | Dec 2008 | B2 |
7698765 | Bobey et al. | Apr 2010 | B2 |
7802332 | Kummer et al. | Sep 2010 | B2 |
8429774 | Tarsaud et al. | Apr 2013 | B2 |
20070143928 | Biggie et al. | Jun 2007 | A1 |
20080271253 | Pile | Nov 2008 | A1 |
Number | Date | Country |
---|---|---|
2249013 | Jul 1974 | DE |
7522889 | Nov 1975 | DE |
2446935 | Apr 1976 | DE |
7334397 | Sep 1976 | DE |
2522863 | Nov 1976 | DE |
7639097 | Jul 1977 | DE |
2614861 | Oct 1977 | DE |
2816642 | Oct 1978 | DE |
2919438 | Nov 1980 | DE |
3217981 | Nov 1982 | DE |
3303615 | Aug 1984 | DE |
3535374 | Apr 1987 | DE |
3716263 | Nov 1988 | DE |
9010880 | Feb 1991 | DE |
0 162 785 | Nov 1958 | EP |
0 034 954 | Sep 1981 | EP |
0 122 666 | Oct 1984 | EP |
0 134 051 | Mar 1985 | EP |
0 168 213 | Jan 1986 | EP |
0 228 233 | Jul 1987 | EP |
0 261 830 | Mar 1988 | EP |
0 275 618 | Jul 1988 | EP |
0 296 689 | Dec 1988 | EP |
0 302 579 | Feb 1989 | EP |
0 311 993 | Apr 1989 | EP |
0 338 472 | Oct 1989 | EP |
0 676 158 | Oct 1995 | EP |
1 056 372 | Dec 2000 | EP |
122806 | Feb 1919 | GB |
762528 | Nov 1956 | GB |
796746 | Jun 1958 | GB |
946831 | Jan 1964 | GB |
949652 | Feb 1964 | GB |
958651 | May 1964 | GB |
959103 | May 1964 | GB |
969367 | Sep 1964 | GB |
1023097 | Mar 1966 | GB |
1059100 | Feb 1967 | GB |
1118740 | Jul 1968 | GB |
1126364 | Sep 1968 | GB |
1222710 | Feb 1971 | GB |
1273342 | May 1972 | GB |
1286197 | Aug 1972 | GB |
1291015 | Sep 1972 | GB |
1341325 | Dec 1973 | GB |
1398544 | Jun 1975 | GB |
1440193 | Jun 1976 | GB |
1442994 | Jul 1976 | GB |
1474018 | May 1977 | GB |
1483045 | Aug 1977 | GB |
1499938 | Feb 1978 | GB |
1545806 | May 1979 | GB |
2026315 | Feb 1980 | GB |
1576641 | Oct 1980 | GB |
2059256 | Apr 1981 | GB |
1595417 | Aug 1981 | GB |
1599422 | Sep 1981 | GB |
1601808 | Nov 1981 | GB |
1602952 | Nov 1981 | GB |
2090734 | Jul 1982 | GB |
2107197 | Apr 1983 | GB |
2108837 | May 1983 | GB |
2134382 | Aug 1984 | GB |
2141333 | Dec 1984 | GB |
2167293 | May 1986 | GB |
2177594 | Jan 1987 | GB |
2177595 | Jan 1987 | GB |
2177906 | Feb 1987 | GB |
2183471 | Jun 1987 | GB |
WO 8404884 | Dec 1984 | WO |
WO 8605973 | Oct 1986 | WO |
WO 86-06624 | Nov 1986 | WO |
WO 8903203 | Apr 1989 | WO |
Number | Date | Country | |
---|---|---|---|
Parent | 12856076 | Aug 2010 | US |
Child | 13857170 | US |